Why We Should Care About Changes In The Pharmaceutical Industry
The pharmaceutical sector is still struggling to find an operating model that will work in the 21st century. The shocking news of GlaxoSmithKline's sale of its cancer-drug business to Novartis -- and the many recent huge deals like it -- are the most recent evidence.